Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Tara C Anderson"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5304-5310 (2021)
Epidemiologic data regarding the risk of Guillain-Barré syndrome (GBS) following herpes zoster (HZ) are limited. We conducted a self-controlled case series analysis using two large national data sources to evaluate the risk of GBS following HZ among
Externí odkaz:
https://doaj.org/article/61a324f1c28d4030a4e086dc1828c4b9
Autor:
Cara B. Janusz, Tara C. Anderson, Andrew J. Leidner, Grace M. Lee, Kathleen Dooling, Lisa A. Prosser
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
The Advisory Committee on Immunization Practices (ACIP) recommends recombinant zoster vaccine (RZV) to prevent against herpes zoster (HZ) and related complications in immunocompetent adults ≥50 y and immunocompromised adults ≥19 y. In 2019, a sta
Externí odkaz:
https://doaj.org/article/60b984d5b82846baa32aac10192e5504
Autor:
Olivia L McGovern, Mark Stenger, Sara E Oliver, Tara C Anderson, Cheryl Isenhour, Matthew R Mauldin, Nia Williams, Eric Griggs, Tonny Bogere, Chris Edens, Aaron T Curns, Joana Y Lively, Yingtao Zhou, Songli Xu, Maureen H Diaz, Jessica L Waller, Kevin R Clarke, Mary E Evans, Elisabeth M Hesse, Sapna Bamrah Morris, Robert P McClung, Laura A Cooley, Naeemah Logan, Andrew T Boyd, Allan W Taylor, Kristina L Bajema, Stephen Lindstrom, Christopher A Elkins, Christopher Jones, Aron J Hall, Samuel Graitcer, Alexandra M Oster, Alicia M Fry, Marc Fischer, Laura Conklin, Runa H Gokhale
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249901 (2021)
BackgroundThe Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), evolved rapidly in the United States. This report describes the demographic, clinical, and epidemiologic characteristi
Externí odkaz:
https://doaj.org/article/ec005edef2014a54a2052f84f6933811
Autor:
Andrew J, Leidner, Tara C, Anderson, Kai, Hong, Ismael R, Ortega-Sanchez, Angela, Guo, Jamison, Pike, Lisa A, Prosser, Kathleen L, Dooling
Publikováno v:
Value in Health. 26:204-215
This study aimed to estimate the cost-effectiveness of the use of recombinant zoster vaccine (RZV) (Shingrix), which protects against herpes zoster (HZ), among immunocompromised adults aged 19 to 49 years, as a contribution to deliberations of the Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaffcf086acb8daf03b394da6d6c0985
https://doi.org/10.1016/j.jval.2022.08.003
https://doi.org/10.1016/j.jval.2022.08.003
Publikováno v:
Vaccine. 40:7187-7190
In 2018, CDC recommended a highly efficacious adjuvanted recombinant zoster vaccine (RZV) as a 2-dose series for prevention of herpes zoster (HZ) for immunocompetent persons age ≥ 50 years, with the 2nd dose recommended 2-6 months after the 1st dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2992e004622182d3494974a58f634f8
https://doi.org/10.1016/j.vaccine.2022.10.065
https://doi.org/10.1016/j.vaccine.2022.10.065
Autor:
Katherine E. Fleming-Dutra, Megan Wallace, Danielle L. Moulia, Evelyn Twentyman, Lauren E. Roper, Elisha Hall, Ruth Link-Gelles, Monica Godfrey, Kate R. Woodworth, Tara C. Anderson, Amy B. Rubis, Edwin Shanley, Jefferson M. Jones, Rebecca L. Morgan, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew Daley, Sarah Meyer, Sara E. Oliver
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:859-868
On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months-5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72b5ed8afaf26923ccfa80ea4023a1af
https://doi.org/10.15585/mmwr.mm7126e2
https://doi.org/10.15585/mmwr.mm7126e2
Autor:
Tara C. Anderson, Thai-An Nguyen, Jennifer K. Adams, Nancy M. Garrett, Cheryl A. Bopp, Joe B. Baker, Carrie McNeil, Paul Torres, Paul J. Ettestad, Matthew M. Erdman, Denise L. Brinson, Thomas M. Gomez, Casey Barton Behravesh
Publikováno v:
One Health, Vol 2, Iss C, Pp 144-149 (2016)
Live poultry-associated salmonellosis is an emerging public health issue in the United States. Public and animal health officials collaborated to investigate one of the largest (356 cases, 39 states) of these outbreaks reported to date. A case was de
Externí odkaz:
https://doaj.org/article/185a446b8ebe40fcb0da57f4f59b5594
Autor:
Tara C. Anderson, Nina B. Masters, Angela Guo, Leah Shepersky, Andrew J. Leidner, Grace M. Lee, Camille N. Kotton, Kathleen L. Dooling
Publikováno v:
American Journal of Transplantation. 22:986-990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d89e23214755a21be317092bbf84818d
https://doi.org/10.1111/ajt.16649
https://doi.org/10.1111/ajt.16649
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 10, Pp 1705-1711 (2016)
Backyard poultry flocks have increased in popularity concurrent with an increase in live poultry–associated salmonellosis (LPAS) outbreaks. Better understanding of practices that contribute to this emerging public health issue is needed. We reviewe
Externí odkaz:
https://doaj.org/article/216252e7a4ce434cba070469f08d79f0
Publikováno v:
Open Forum Infectious Diseases. 9
Background The varicella vaccination program was implemented in the United States in 1995 and has resulted in large reductions in varicella disease burden. At the start of the varicella vaccination program, impacts on herpes zoster (HZ) epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede06269bead26753efcf85fb2f7a95d
https://doi.org/10.1093/ofid/ofac492.1288
https://doi.org/10.1093/ofid/ofac492.1288